2024 Q2 Form 10-Q Financial Statement

#000162828024019989 Filed on May 02, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $284.3M $269.4M $213.5M
YoY Change 24.42% 26.18% 33.86%
Cost Of Revenue $48.10M $45.72M $40.20M
YoY Change 13.7% 13.73% 20.61%
Gross Profit $236.2M $223.7M $173.3M
YoY Change 26.86% 29.07% 37.36%
Gross Profit Margin 83.08% 83.03% 81.17%
Selling, General & Admin $178.7M $172.0M $162.6M
YoY Change 6.32% 5.82% 18.59%
% of Gross Profit 75.65% 76.89% 93.78%
Research & Development $72.31M $70.60M $80.04M
YoY Change -0.04% -11.79% 32.83%
% of Gross Profit 30.61% 31.56% 46.18%
Depreciation & Amortization $20.84M $20.05M $16.87M
YoY Change 20.23% 18.83% 11.4%
% of Gross Profit 8.82% 8.96% 9.74%
Operating Expenses $251.0M $242.6M $242.6M
YoY Change 2.79% 0.01% 22.94%
Operating Profit -$14.78M -$18.91M -$69.26M
YoY Change -74.51% -72.7% -2.63%
Interest Expense $5.408M $479.0K $496.0K
YoY Change 21.47% -3.43% 1.02%
% of Operating Profit
Other Income/Expense, Net -$148.0K -$344.0K -$210.0K
YoY Change -108.61% 63.81% -138.67%
Pretax Income -$5.821M -$10.70M -$63.39M
YoY Change -88.92% -83.12% -10.83%
Income Tax $500.0K $300.0K $100.0K
% Of Pretax Income
Net Earnings -$6.311M -$10.97M -$63.45M
YoY Change -88.07% -82.72% -11.16%
Net Earnings / Revenue -2.22% -4.07% -29.71%
Basic Earnings Per Share -$0.04 -$0.08 -$0.45
Diluted Earnings Per Share -$0.04 -$0.08 -$0.45
COMMON SHARES
Basic Shares Outstanding 146.3M shares 144.9M shares 140.3M
Diluted Shares Outstanding 146.9M shares 145.5M shares 139.6M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $735.4M $744.6M $602.8M
YoY Change 21.96% 23.52% 2.71%
Cash & Equivalents $356.2M $427.7M $329.0M
Short-Term Investments $379.1M $317.0M $273.8M
Other Short-Term Assets $41.47M $41.71M $41.78M
YoY Change -5.12% -0.17% 2.57%
Inventory
Prepaid Expenses
Receivables $158.7M $139.0M $106.2M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $966.5M $954.9M $775.0M
YoY Change 21.13% 23.22% 6.78%
LONG-TERM ASSETS
Property, Plant & Equipment $34.90M $35.42M $38.28M
YoY Change -69.13% -7.48% -69.68%
Goodwill $550.4M $539.1M $539.1M
YoY Change 2.03% 0.0% -0.17%
Intangibles $142.3M $127.7M
YoY Change
Long-Term Investments $45.43M
YoY Change
Other Assets $19.32M $18.87M $21.86M
YoY Change 3.63% -13.66% -9.26%
Total Long-Term Assets $1.001B $923.8M $936.2M
YoY Change 7.81% -1.33% -1.09%
TOTAL ASSETS
Total Short-Term Assets $966.5M $954.9M $775.0M
Total Long-Term Assets $1.001B $923.8M $936.2M
Total Assets $1.967B $1.879B $1.711B
YoY Change 13.97% 9.79% 2.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $26.95M $16.45M $19.45M
YoY Change 73.44% -15.45% 35.0%
Accrued Expenses $71.25M $67.01M $69.63M
YoY Change 18.58% -3.76% 18.22%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $624.8M $595.0M $514.7M
YoY Change 20.18% 15.6% 25.96%
LONG-TERM LIABILITIES
Long-Term Debt $42.47M $43.08M $45.13M
YoY Change -4.72% -4.55% -3.88%
Other Long-Term Liabilities $5.278M $5.876M $4.245M
YoY Change -88.29% 38.42% -91.89%
Total Long-Term Liabilities $5.278M $5.876M $4.245M
YoY Change -94.11% 38.42% -95.72%
TOTAL LIABILITIES
Total Short-Term Liabilities $624.8M $595.0M $514.7M
Total Long-Term Liabilities $5.278M $5.876M $4.245M
Total Liabilities $711.2M $685.0M $606.8M
YoY Change 16.69% 12.89% 19.48%
SHAREHOLDERS EQUITY
Retained Earnings -$1.156B -$1.150B -$1.013B
YoY Change 8.51% 13.55%
Common Stock $15.00K $15.00K $14.00K
YoY Change 7.14% 7.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.256B $1.194B $1.104B
YoY Change
Total Liabilities & Shareholders Equity $1.967B $1.879B $1.711B
YoY Change 13.97% 9.79% 2.33%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$6.311M -$10.97M -$63.45M
YoY Change -88.07% -82.72% -11.16%
Depreciation, Depletion And Amortization $20.84M $20.05M $16.87M
YoY Change 20.23% 18.83% 11.4%
Cash From Operating Activities $58.70M $69.15M $29.28M
YoY Change -602.65% 136.19% 184.67%
INVESTING ACTIVITIES
Capital Expenditures $15.88M $2.089M $2.173M
YoY Change 33.24% -3.87% -71.12%
Acquisitions $5.000K $0.00
YoY Change
Other Investing Activities -$130.7M $6.933M $10.05M
YoY Change 737.98% -30.98% -1067.73%
Cash From Investing Activities -$146.6M -$4.670M -$79.00K
YoY Change 432.74% 5811.39% -99.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 15.76M $6.676M $3.312M
YoY Change -20.03% 101.57% -49.37%
NET CHANGE
Cash From Operating Activities 58.70M $69.15M $29.28M
Cash From Investing Activities -146.6M -$4.670M -$79.00K
Cash From Financing Activities 15.76M $6.676M $3.312M
Net Change In Cash -72.17M $71.15M $32.51M
YoY Change 270.18% 118.87% 5051.82%
FREE CASH FLOW
Cash From Operating Activities $58.70M $69.15M $29.28M
Capital Expenditures $15.88M $2.089M $2.173M
Free Cash Flow $42.81M $67.06M $27.10M
YoY Change -281.42% 147.42% 882.31%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
317175000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
320166000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
18551000 usd
CY2024Q1 us-gaap Assets
Assets
1878710000 usd
CY2023Q4 us-gaap Assets
Assets
1893568000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
16446000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
13177000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
67008000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
100075000 usd
CY2024Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
487944000 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
501903000 usd
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
23585000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
27275000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
594983000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
642430000 usd
CY2024Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
7403000 usd
CY2023Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
7692000 usd
CY2024Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
43076000 usd
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
43581000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
33691000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
37923000 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5876000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6332000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
685029000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
737958000 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
144806464 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
144806464 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
15000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
15000 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2345537000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2295807000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2068000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1375000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1149803000 usd
CY2024Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
88409000 usd
CY2023Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
83045000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
35417000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
36258000 usd
CY2024Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
33712000 usd
CY2023Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
34375000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
36727000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
539131000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
539354000 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
18870000 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
146271803 shares
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1138837000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1193681000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1155610000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1878710000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1893568000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
269428000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
213526000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
44141000 usd
CY2024Q1 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
43757000 usd
CY2023Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
44564000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
127747000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
137546000 usd
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
146271803 shares
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
45723000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
40202000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
223705000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
173324000 usd
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
120994000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
117363000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
70599000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
80036000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
51018000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
45188000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
242611000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
242587000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-18906000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-69263000 usd
CY2024Q1 pcor Interest Income
InterestIncome
5938000 usd
CY2023Q1 pcor Interest Income
InterestIncome
4948000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
479000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
496000 usd
CY2024Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
3088000 usd
CY2023Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1632000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-344000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-210000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10703000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-63389000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
263000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
58000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-10966000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-63447000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
145476006 shares
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145476006 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
139646465 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
139646465 shares
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-486000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-16000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-207000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
324000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-693000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
308000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11659000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-63139000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1116780000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3651000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
47060000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
308000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-63447000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1104352000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1155610000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7140000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
42590000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-693000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-10966000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1193681000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-10966000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-63447000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
40132000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
44938000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20051000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16874000 usd
CY2024Q1 pcor Accretion Amortization Of Discounts And Premiums Investments Non Cash
AccretionAmortizationOfDiscountsAndPremiumsInvestmentsNonCash
3088000 usd
CY2023Q1 pcor Accretion Amortization Of Discounts And Premiums Investments Non Cash
AccretionAmortizationOfDiscountsAndPremiumsInvestmentsNonCash
1632000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-268000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-441000 usd
CY2024Q1 pcor Noncash Operating Lease Expense
NoncashOperatingLeaseExpense
2734000 usd
CY2023Q1 pcor Noncash Operating Lease Expense
NoncashOperatingLeaseExpense
2628000 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-1079000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-408000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
189000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1726000 usd
CY2024Q1 us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
759000 usd
CY2023Q1 us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
36000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-68013000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-42948000 usd
CY2024Q1 pcor Increase Decrease In Deferred Contract Cost Assets
IncreaseDecreaseInDeferredContractCostAssets
427000 usd
CY2023Q1 pcor Increase Decrease In Deferred Contract Cost Assets
IncreaseDecreaseInDeferredContractCostAssets
460000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
684000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4549000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3155000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4648000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-34154000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-28181000 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-14108000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
6489000 usd
CY2024Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2291000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2620000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
69145000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
29275000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2089000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2173000 usd
CY2024Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
9514000 usd
CY2023Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
7951000 usd
CY2024Q1 pcor Payments To Acquire Strategic Investments
PaymentsToAcquireStrategicInvestments
210000 usd
CY2023Q1 pcor Payments To Acquire Strategic Investments
PaymentsToAcquireStrategicInvestments
149000 usd
CY2024Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
101434000 usd
CY2023Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
89996000 usd
CY2024Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
107301000 usd
CY2023Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
103909000 usd
CY2024Q1 pcor Proceeds To Acquire Originations Of Materials Financing
ProceedsToAcquireOriginationsOfMaterialsFinancing
0 usd
CY2023Q1 pcor Proceeds To Acquire Originations Of Materials Financing
ProceedsToAcquireOriginationsOfMaterialsFinancing
9077000 usd
CY2024Q1 pcor Proceeds To Acquire Customer Repayments Of Materials Financing
ProceedsToAcquireCustomerRepaymentsOfMaterialsFinancing
1281000 usd
CY2023Q1 pcor Proceeds To Acquire Customer Repayments Of Materials Financing
ProceedsToAcquireCustomerRepaymentsOfMaterialsFinancing
5358000 usd
CY2024Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
5000 usd
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4670000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-79000 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7125000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3722000 usd
CY2024Q1 pcor Repayments Of Long Term Finance Lease Obligations Net Of Proceeds From Lease Incentives
RepaymentsOfLongTermFinanceLeaseObligationsNetOfProceedsFromLeaseIncentives
449000 usd
CY2023Q1 pcor Repayments Of Long Term Finance Lease Obligations Net Of Proceeds From Lease Incentives
RepaymentsOfLongTermFinanceLeaseObligationsNetOfProceedsFromLeaseIncentives
410000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6676000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3312000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
71151000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
32508000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1285000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-256000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
357790000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
299816000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
427656000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
332068000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
427656000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
328964000 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
0 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
3104000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
427656000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
332068000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
171000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
79000 usd
CY2024Q1 pcor Stock Based Compensation Capitalized For Cloud Computing Arrangement Costs
StockBasedCompensationCapitalizedForCloudComputingArrangementCosts
32000 usd
CY2023Q1 pcor Stock Based Compensation Capitalized For Cloud Computing Arrangement Costs
StockBasedCompensationCapitalizedForCloudComputingArrangementCosts
69000 usd
CY2024Q1 pcor Operating Cash Flows From Lease Incentives
OperatingCashFlowsFromLeaseIncentives
197000 usd
CY2023Q1 pcor Operating Cash Flows From Lease Incentives
OperatingCashFlowsFromLeaseIncentives
239000 usd
CY2024Q1 pcor Operating Cash Flows From Finance Leases
OperatingCashFlowsFromFinanceLeases
477000 usd
CY2023Q1 pcor Operating Cash Flows From Finance Leases
OperatingCashFlowsFromFinanceLeases
496000 usd
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
2879000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
3119000 usd
CY2024Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
532000 usd
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
496000 usd
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1101000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1306000 usd
CY2024Q1 pcor Increase Decrease In Accruals For Capitalized Software Development Costs
IncreaseDecreaseInAccrualsForCapitalizedSoftwareDevelopmentCosts
1977000 usd
CY2023Q1 pcor Increase Decrease In Accruals For Capitalized Software Development Costs
IncreaseDecreaseInAccrualsForCapitalizedSoftwareDevelopmentCosts
2088000 usd
CY2024Q1 pcor Stock Based Compensation Capitalized For Software Development
StockBasedCompensationCapitalizedForSoftwareDevelopment
2426000 usd
CY2023Q1 pcor Stock Based Compensation Capitalized For Software Development
StockBasedCompensationCapitalizedForSoftwareDevelopment
2053000 usd
CY2024Q1 pcor Deferred Asset Acquisition Costs Incurred But Not Yet Paid
DeferredAssetAcquisitionCostsIncurredButNotYetPaid
1400000 usd
CY2023Q1 pcor Deferred Asset Acquisition Costs Incurred But Not Yet Paid
DeferredAssetAcquisitionCostsIncurredButNotYetPaid
0 usd
CY2024Q1 pcor Right Of Use Asset Obtained Or Modified In Exchange For Operating Lease Liability
RightOfUseAssetObtainedOrModifiedInExchangeForOperatingLeaseLiability
-4508000 usd
CY2023Q1 pcor Right Of Use Asset Obtained Or Modified In Exchange For Operating Lease Liability
RightOfUseAssetObtainedOrModifiedInExchangeForOperatingLeaseLiability
2615000 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt;text-indent:24.48pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-bottom:12pt;text-indent:24.48pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Management periodically evaluates its estimates and assumptions for continued reasonableness, primarily with respect to revenue recognition, the period of benefit of contract cost assets, the fair value of assets acquired and liabilities assumed in a business combination or asset acquisition, stock-based compensation expense, the recoverability of goodwill and long-lived assets, useful lives of long-lived assets, capitalization of software development costs, income taxes, including related reserves and allowances, provision for credit losses, incremental borrowing rates and estimation of lease terms applied in lease accounting, and self-insurance reserve estimates. Appropriate adjustments, if any, to the estimates used are made prospectively based upon such periodic evaluation. Management bases its estimates on historical experience and on various other assumptions that management believes to be reasonable. Actual results could differ from the Company’s estimates.</span></div>
CY2024Q1 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0 usd
CY2024Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0 usd
CY2023Q4 us-gaap Investments
Investments
11527000 usd
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2023Q1 us-gaap Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded
DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded
0 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded
DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded
0 usd
CY2024Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
600000 usd
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
2100000 usd
CY2023Q4 us-gaap Receivables From Customers
ReceivablesFromCustomers
5700000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
3800000 usd
CY2024Q1 us-gaap Receivables From Customers
ReceivablesFromCustomers
3500000 usd
CY2024Q1 us-gaap Self Insurance Reserve
SelfInsuranceReserve
3100000 usd
CY2023Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
3300000 usd
CY2024Q1 pcor Interest Accrued On Available For Sale Debt Securities
InterestAccruedOnAvailableForSaleDebtSecurities
2000 usd
CY2024Q1 pcor Payments To Acquire Strategic Investments
PaymentsToAcquireStrategicInvestments
210000 usd
CY2024Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
759000 usd
CY2024Q1 us-gaap Investments
Investments
12498000 usd
CY2022Q4 us-gaap Investments
Investments
11043000 usd
CY2023Q1 pcor Interest Accrued On Available For Sale Debt Securities
InterestAccruedOnAvailableForSaleDebtSecurities
2000 usd
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
220600000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
171500000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1000000000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
704700000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.70
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
302200000 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
317175000 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
16000 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
228000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
316963000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
320166000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
186000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
191000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
320161000 usd
CY2024Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
107300000 usd
CY2023Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
103900000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0 usd
CY2023Q1 pcor Payments To Acquire Strategic Investments
PaymentsToAcquireStrategicInvestments
149000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
36000 usd
CY2023Q1 us-gaap Investments
Investments
11230000 usd
CY2023Q1 pcor Impairment Losses On Strategic Investments
ImpairmentLossesOnStrategicInvestments
0 usd
CY2024Q1 pcor Impairment Losses On Strategic Investments
ImpairmentLossesOnStrategicInvestments
0 usd
CY2024Q1 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
364000 usd
CY2024Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
708216000 usd
CY2023Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
362000 usd
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
623975000 usd
CY2024Q1 pcor Lessee Operating Lease Increase Decrease In Liability To Be Paid
LesseeOperatingLeaseIncreaseDecreaseInLiabilityToBePaid
10700000 usd
CY2023 us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
2800000 usd
CY2023Q1 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 usd
CY2024Q1 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
232670000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
107771000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
124899000 usd
CY2024Q1 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P4Y1M6D
CY2024Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
235518000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
107771000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
127747000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
232803000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
98105000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
134698000 usd
CY2023Q4 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P4Y3M18D
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
235651000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
98105000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
137546000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9666000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9334000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
539100000 usd
CY2023Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2024Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2024Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
8470000 usd
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
31786000 usd
CY2024Q1 pcor Accrued Commissions
AccruedCommissions
10721000 usd
CY2023Q4 pcor Accrued Commissions
AccruedCommissions
16494000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
39036000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
36171000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8781000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
15624000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
67008000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
100075000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4340052 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.57
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
471310 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
15.15
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3868742 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.25
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3868742 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
12.25
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
0 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
40132000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
44938000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
2458000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
2122000 usd
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
42590000 usd
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
47060000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
100000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11588374 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14191239 shares
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
269428000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
213526000 usd
CY2024Q1 us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.04
CY2024Q1 us-gaap Restructuring Charges
RestructuringCharges
4185000 usd
CY2024Q1 us-gaap Restructuring Reserve
RestructuringReserve
400000 usd
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001628280-24-019989-index-headers.html Edgar Link pending
0001628280-24-019989-index.html Edgar Link pending
0001628280-24-019989.txt Edgar Link pending
0001628280-24-019989-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
headerlogo.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
pcor-20240331.htm Edgar Link pending
pcor-20240331.xsd Edgar Link pending
pcor-q124x10xqxexx101.htm Edgar Link pending
pcor-q124x10xqxexx102.htm Edgar Link pending
pcor-q124x10xqxexx103.htm Edgar Link pending
pcor-q124x10xqxexx311.htm Edgar Link pending
pcor-q124x10xqxexx312.htm Edgar Link pending
pcor-q124x10xqxexx321.htm Edgar Link pending
pcor-q124x10xqxexx322.htm Edgar Link pending
pcorlogoa.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pcor-20240331_cal.xml Edgar Link unprocessable
pcor-20240331_def.xml Edgar Link unprocessable
pcor-20240331_lab.xml Edgar Link unprocessable
pcor-20240331_pre.xml Edgar Link unprocessable
pcor-20240331_htm.xml Edgar Link completed
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending